If Medicare coverage eventually follows commercial payers, DexCom would gain access to millions of additional patients, ...
Following expanded FDA approval for pediatric patients, the over-the-counter Stelo continuous glucose monitor is adding AI ...
DexCom (DXCM) faces GLP-1 disruption as it targets non-insulin Type 2 CGM growth. Read here for a detailed invesment analysis ...
Morning Overview on MSN
The FDA cleared the first over-the-counter glucose monitor made for children
Parents of young children with elevated blood sugar now have a new option that does not require a doctor’s prescription. The ...
AI may help smartwatches make glucose data more useful through better predictions, pattern detection, and personalized health ...
Continuous glucose monitors have become popular among those who need to track their glucose levels because they're painless ...
Abstract: For the large-scale monitoring of a physical phenomena using a wireless sensor network (WSN), a large number of static and/or mobile sensor nodes are required, resulting in higher deployment ...
On the other hand, DexCom is a pure-play CGM company whose target market consists mainly of people with Type 1 and Type 2 ...
A continuous glucose monitor is a coin-sized plastic disc, a filament thinner than a hair that sits just under the skin, and ...
Samsung Galaxy Watch blood sugar tracking is still a rumor, not reality. Here’s the timeline, research, current options, and what users can do today.
Apple Watch blood sugar tracking remains unconfirmed. Here's the latest on the timeline, patents, technical challenges, and what Apple Watch can do now.
Michelle Tarver, director of the FDA’s Center for Devices and Radiological Health, said in the announcement that the clearance reflects the agency’s commitment to fostering innovation for pediatric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results